Latest research
Latest corporate research
Latest tax advantaged reviews
Subscribe to our latest research
What we do
Investment research services
Tax enhanced research services
Bespoke consulting services
About
About Hardman & Co
Case studies
The team
News, podcasts & insights
Contact us
Our team
News & events
About Hardman & Co
Case studies
The team
News, podcasts & insights
Contact us
×
Latest corporate investment research
Detailed company analysis created specifically for investors
Latest tax advantaged research
Product reports for investors and advisors
Latest published research
Apax Global Alpha
1H’24: deal activity coming back strongly
26th Sep 2024
Chesnara Plc
Steady as she goes!
26th Sep 2024
Services for corporates
Investment research & analysis
Detailed company analysis created specifically for investors
Bespoke valuation services
Bespoke valuation services
Services for clients with specific needs
Services for funds
Tax advantaged research
Product reports for investors and advisors.
About
About Hardman & Co.
We are the longest-established commissioned research provider.
Insights
Group
Created with Sketch.
Podcasts
Group
Created with Sketch.
Videos
Group
Created with Sketch.
Events
Group
Created with Sketch.
See all news
Group
Created with Sketch.
Podcast
The EIS Navigator
Latest Episode
103: What Seedrs data tells us about crowdfunding and venture investing | Jeff Lynn of Republic Europe
Stay up-to-date with the latest research
Sign up to our newsletter
Search Results
You searched for:
“CTAL-TTA Valid Test Preparation 🅾 CTAL-TTA Valid Test Tips 👕 Exam CTAL-TTA Quiz 📎 Easily obtain â–› CTAL-TTA â–Ÿ for free download through ⇛ www.pdfvce.com ⇚ 🦩Exam CTAL-TTA Format
”
96: How EIS and VCTs fit in a financial plan and how to pick the right products for your clients | Rob Bell of Finova Money
accesso Technology Group
Technology
SIS Ventures Limited
Technology
99: Building a medical company without a specialist background | Clare Brenner of Myogenes
100: Building a venture firm, assessing founders and science-based investing | Mark Beaumont of Eos Advisory
102: EIS is 30! Discussing the past, present and future of the scheme | Christiana Stewart-Lockhart of the EIS Association
MIFID II dampening liquidity and cutting research
2: Creating an investment process | Reuben Wilcock of Blackfinch
16: Marketing for startups | Rajeev Saxena of Velocity Capital Advisors
Investing in a broad spectrum of the drug industry
32: Building a second multi-million-pound exit and lessons learnt | Scott Weavers-Wright of Haatch Ventures
Prev
1
...
30
31
32
33
34
...
41
Next